• Policy
• The authorities is monitoring Sputnik V's overseas data
• by Kim, Jung-Ju Apr 26, 2021 05:51am

• Policy
• Price cuts for Lixiana and Lenvima due to increased usage
• by Kim, Jung-Ju Apr 26, 2021 05:51am

• Opinion
• [Reporter’s View] Interest in the role and vision of GAs
• by Eo, Yun-Ho Apr 26, 2021 05:51am

• Company
• Ninlaro can be prescribed at general hospitals
• by Eo, Yun-Ho Apr 26, 2021 01:34am

• Policy
• Rucalo & Xeljanz are subject to usage monitoring in 2Q
• by Lee, Hye-Kyung Apr 26, 2021 01:32am

• Company
• The market share of Hanmi & Chong Kun Dang's is 16%
• by Kim, Jin-Gu Apr 26, 2021 01:29am

• Company
• Domestic drug Rosuzet/K-CAB sales performance is very good
• by An, Kyung-Jin Apr 26, 2021 01:28am

• Tamiflu hit hard by COVID-19, prescription drops 99.9%
• by Chon, Seung-Hyun Apr 23, 2021 05:53am

• Company
• Big 5 Hospitals actively prepare CAR-T ‘Kymria' centers
• by Eo, Yun-Ho Apr 22, 2021 05:53am

• Company
• Tremfya reimbursement approved for palmoplantar pustulosis
• by Apr 22, 2021 05:53am